CLEVELAND, Ohio, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Innovest Global Inc. (OTC Markets: IVST) (the “Company” or “Innovest”), a conglomerate with operations in commercial and industrial products and services, biotechnology, and construction & building materials, has secured a strategic partnership with the Southern California Biomedical Counsel. This action follows the annoucement of our Biotech Division’s world-class advisory board, and is a catalyst for the division’s 2019 business plan.
Southern California Biomedical Counsel (SoCal Bio) is a non-profit that supports the growth of biotech, medtech, and digital health commercialization activities in the flourishing Los Angeles region. They are the leading Los Angeles biotech trade association with influence in the scientific, finacial, corporate, and government sectors.
“The announcement of our team last week, and now this alignemnt with SoCal Bio signifies the end of our planning and the beginning of our execution. SoCal Bio is an ideal platform that is active with prime opportunities on the west coast that fit our requirements,” said Dr. Dwain Morris-Irvin, Innovest Biotech Division President.
“This is a major development from Dr. Irvin, which appropriately puts our biotech division in a league of its own,” said Dan Martin, Innovest’s Chief Executive Officer. “Dr. Irvin precisely meets the needs of a niche with a first class team, and is poised to surpass the goal we initially defined. In addition to SoCal Bio being a preeminent organization, Ahmed Enany (SoCal Chief Executive Officer) is one of the kindest and most down to earth people I’ve ever had the pleasure to meet. Once again, I am so thankful for having the opportunity to align with such good people.”
Innovest’s biotechnology division expects a variety of developments, from both StemVax and its new efforts. Innovest is enthusiastically closing out a year which was marked by a series of developments and revenue acquistions, which effectivelty set a platform that can scale significantly in 2019 and beyond.
About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in three divisions, which include commercial and industrial products and services, energy, biotechnology, health sciences, construction, and building materials. The primary growth strategy of Innovest Global Inc is to acquire existing companies in a select few industries and attract new customers in cost effective ways. Currently, Innovest Global Inc has a Commercial & Industrial Division, a Biotechnology & Health Services Division, and a Construction & Building Materials Division.
For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.
Contact Information
Corporate Office:
(216) 815-1122
Twitter @innovestglobal
Investor Relations:
Hayden IR
(917) 658-7878